These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
56 related articles for article (PubMed ID: 9039879)
21. Clinical value of HIV p24 Ag in cerebrospinal fluid of symptomatic or asymptomatic HIV-infected patients. Carbonara S; Angarano G; Zimatore GB; Fiore JR; Laddago V; Santantonio T; Pastore G Acta Neurol (Napoli); 1990 Feb; 12(1):44-8. PubMed ID: 2110716 [No Abstract] [Full Text] [Related]
22. Cerebrospinal fluid catecholamine metabolites in HIV-infected patients. Larsson M; Hagberg L; Forsman A; Norkrans G J Neurosci Res; 1991 Mar; 28(3):406-9. PubMed ID: 1856886 [TBL] [Abstract][Full Text] [Related]
23. Reduced expression of excitatory amino acid transporter 2 and diffuse microglial activation in the cerebral cortex in AIDS cases with or without HIV encephalitis. Xing HQ; Hayakawa H; Gelpi E; Kubota R; Budka H; Izumo S J Neuropathol Exp Neurol; 2009 Feb; 68(2):199-209. PubMed ID: 19151621 [TBL] [Abstract][Full Text] [Related]
25. Markers of AIDS dementia complex: the role of cerebrospinal fluid assays. Brew BJ AIDS; 2001 Sep; 15(14):1883-4. PubMed ID: 11579253 [No Abstract] [Full Text] [Related]
26. Oxidative stress and therapeutic approaches in HIV dementia. Steiner J; Haughey N; Li W; Venkatesan A; Anderson C; Reid R; Malpica T; Pocernich C; Butterfield DA; Nath A Antioxid Redox Signal; 2006; 8(11-12):2089-100. PubMed ID: 17034352 [TBL] [Abstract][Full Text] [Related]
27. Beta-chemokines MCP-1 and RANTES are selectively increased in cerebrospinal fluid of patients with human immunodeficiency virus-associated dementia. Kelder W; McArthur JC; Nance-Sproson T; McClernon D; Griffin DE Ann Neurol; 1998 Nov; 44(5):831-5. PubMed ID: 9818943 [TBL] [Abstract][Full Text] [Related]
28. HIV-1 isolation and p24-antigen detection in cerebrospinal fluid of subjects with neurological abnormalities related to AIDS. D'Agaro P; Andrian P; Roscioli B; Mascioli M; Dal Molin G; Comar M; Faruzzo A; Majori L Acta Neurol (Napoli); 1990 Feb; 12(1):49-52. PubMed ID: 2110717 [No Abstract] [Full Text] [Related]
29. Increased cerebrospinal fluid levels of soluble receptors for tumour necrosis factor in HIV-infected patients with neurological diseases. Vullo V; Mastroianni CM; Lichtner M; Mengoni F; Delia S AIDS; 1995 Sep; 9(9):1099-100. PubMed ID: 8527085 [No Abstract] [Full Text] [Related]
30. Involvement of microglia in cerebrospinal fluid glutamate increase in SIV-infected rhesus monkeys (Macaca mulatta). Koutsilieri E; Sopper S; Heinemann T; Scheller C; Lan J; Stahl-Hennig C; ter Meulen V; Riederer P; Gerlach M AIDS Res Hum Retroviruses; 1999 Mar; 15(5):471-7. PubMed ID: 10195757 [TBL] [Abstract][Full Text] [Related]
31. A potential role for interferon-alpha in the pathogenesis of HIV-associated dementia. Rho MB; Wesselingh S; Glass JD; McArthur JC; Choi S; Griffin J; Tyor WR Brain Behav Immun; 1995 Dec; 9(4):366-77. PubMed ID: 8903853 [TBL] [Abstract][Full Text] [Related]
32. Cerebrospinal fluid neopterin in human immunodeficiency virus type 1 infection. Brew BJ; Bhalla RB; Paul M; Gallardo H; McArthur JC; Schwartz MK; Price RW Ann Neurol; 1990 Oct; 28(4):556-60. PubMed ID: 2252366 [TBL] [Abstract][Full Text] [Related]
33. Elevated alpha-tumor necrosis factor levels in spinal fluid from HIV-1-infected patients with central nervous system involvement. Grimaldi LM; Martino GV; Franciotta DM; Brustia R; Castagna A; Pristerà R; Lazzarin A Ann Neurol; 1991 Jan; 29(1):21-5. PubMed ID: 1996875 [TBL] [Abstract][Full Text] [Related]
34. Elevated glutamine/glutamate ratio in cerebrospinal fluid of first episode and drug naive schizophrenic patients. Hashimoto K; Engberg G; Shimizu E; Nordin C; Lindström LH; Iyo M BMC Psychiatry; 2005 Jan; 5():6. PubMed ID: 15683541 [TBL] [Abstract][Full Text] [Related]
35. HIV type 1 V3 sequences and the development of dementia during AIDS. Di Stefano M; Wilt S; Gray F; Dubois-Dalcq M; Chiodi F AIDS Res Hum Retroviruses; 1996 Apr; 12(6):471-6. PubMed ID: 8679301 [TBL] [Abstract][Full Text] [Related]
36. Cerebrospinal fluid human immunodeficiency virus type 1 (HIV-1) p24 antigen levels in HIV-1-related dementia. Royal W; Selnes OA; Concha M; Nance-Sproson TE; McArthur JC Ann Neurol; 1994 Jul; 36(1):32-9. PubMed ID: 7912918 [TBL] [Abstract][Full Text] [Related]
37. Neutralizing antibody responses in patients with AIDS with neurologic complications. Beilke MA; Minagawa H; Stone G; Leon-Monzon M; Gibbs CJ J Lab Clin Med; 1991 Dec; 118(6):585-8. PubMed ID: 1744507 [TBL] [Abstract][Full Text] [Related]
38. Markers of glutamate signaling in cerebrospinal fluid and serum from patients with bipolar disorder and healthy controls. Pålsson E; Jakobsson J; Södersten K; Fujita Y; Sellgren C; Ekman CJ; Ågren H; Hashimoto K; Landén M Eur Neuropsychopharmacol; 2015 Jan; 25(1):133-40. PubMed ID: 25482684 [TBL] [Abstract][Full Text] [Related]